Medicenna Therapeutics Corp.
MDNAF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001807983
No open-market purchases or sales by Medicenna Therapeutics Corp. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Medicenna Therapeutics Corp. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −5 vs. Q1 2021
- Shares held
- 5.02M
- −515.4K (−9.3%) vs. Q1 2021
- Total value
- $15.4M
- −$7.49M (−32.7%) vs. Q1 2021
- New holders
- 4
- 13 more added
- Sold out
- 9
- 4 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDNAF on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 1 | $200.4K |
| Q3 2024 | 1 | $175.0K |
| Q2 2024 | 1 | $145.0K |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 3 | $40.9K |
| Q3 2023 | 26 | $2.45M |
| Q2 2023 | 28 | $4.75M |
| Q1 2023 | 28 | $6.25M |
| Q4 2022 | 28 | $4.75M |
| Q3 2022 | 29 | $9.67M |
| Q2 2022 | 19 | $5.41M |
| Q1 2022 | 20 | $5.47M |
| Q4 2021 | 23 | $7.42M |
| Q3 2021 | 25 | $8.66M |
| Q2 2021 | 26 | $15.4M |
| Q1 2021 | 31 | $22.9M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Medicenna Therapeutics Corp.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 19 | $0 | 0.00% | +19 | New |
| Federation des caisses Desjardins du Quebec | 1,000 | $2.98K | 0.00% | −2,900−74.4% | Reduced |
| Tower Research Capital LLC (TRC) | 1,157 | $3.00K | 0.00% | +121+11.7% | Added |
| Advisor Group Holdings, Inc. | 2,676 | $9.00K | 0.00% | +500+23.0% | Added |
| Deutsche Bank AG | 8,200 | $25.0K | 0.00% | +800+10.8% | Added |
| Royal Bank of Canada | 15,977 | $48.0K | 0.00% | +4,549+39.8% | Added |
| Geode Capital Management, LLC | 22,436 | $67.0K | 0.00% | +2,674+13.5% | Added |
| Patriot Financial Group Insurance Agency, LLC | 22,900 | $69.0K | 0.01% | +2,350+11.4% | Added |
| Citadel Advisors LLC | 24,203 | $73.0K | 0.00% | +24,203 | New |
| Davenport & Co LLC | 25,150 | $76.0K | 0.00% | +25,150 | New |
| JPMorgan Chase & Co | 25,500 | $77.0K | 0.00% | +16,100+171.3% | Added |
| McKinley Carter Wealth Services, Inc. | 32,237 | $97.0K | 0.01% | +7,143+28.5% | Added |
| Renaissance Technologies LLC | 32,446 | $98.0K | 0.00% | −108,754−77.0% | Reduced |
| Rathbone Brothers plc | 40,000 | $121.0K | 0.00% | 00.0% | Unchanged |
| Bank of Montreal | 45,250 | $144.0K | 0.00% | +36,263+403.5% | Added |
| Morgan Stanley | 63,605 | $192.0K | 0.00% | −3,993−5.9% | Reduced |
| Maven Securities LTD | 79,118 | $234.0K | 0.02% | −108,671−57.9% | Reduced |
| Tocqueville Asset Management L.P. | 97,700 | $294.0K | 0.00% | +5,100+5.5% | Added |
| Silverarc Capital Management, LLC | 110,515 | $333.0K | 0.18% | +2,979+2.8% | Added |
| Worth Venture Partners, LLC | 215,030 | $647.0K | 0.24% | +17,130+8.7% | Added |
| ACT Capital Management, LLC | 350,000 | $1.05M | 0.54% | +350,000 | New |
| Intact Investment Management Inc. | 385,600 | $1.43M | 0.04% | 00.0% | Unchanged |
| Verition Fund Management LLC | 539,051 | $1.62M | 0.02% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 915,000 | $2.77M | 0.75% | +75,000+8.9% | Added |
| Board of Trustees of The Leland Stanford Junior University | 962,932 | $2.90M | 0.27% | 00.0% | Unchanged |
| AWM Investment Company, Inc. | 1,000,000 | $3.02M | 0.30% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −529,325−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −122,488−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −80,401−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −39,000−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −36,902−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −27,823−100.0% | Sold out |
| Marshall Wace North America L.P. | 0 | $0 | 0.00% | −19,300−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −5,775−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −111−100.0% | Sold out |